GILEAD SCIENCES, INC. Net Income Loss

• GILEAD SCIENCES, INC. showed an increase of +1,672.9% in Net Income Loss from 2024 to 2025.
• This data is from GILEAD SCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), GILEAD SCIENCES, INC.'s Net Income Loss has grown by 330.0%.
• Historical annual values: Fiscal year 2025: $8.51 billion | Fiscal year 2024: $480.00 million | Fiscal year 2023: $5.67 billion | Fiscal year 2022: $4.59 billion | Fiscal year 2021: $6.23 billion | Fiscal year 2020: $123.00 million | Fiscal year 2019: $5.39 billion | Fiscal year 2018: $5.46 billion | Fiscal year 2017: $4.63 billion | Fiscal year 2016: $13.50 billion | Fiscal year 2015: $18.11 billion | Fiscal year 2014: $12.10 billion | Fiscal year 2013: $3.08 billion | Fiscal year 2012: $2.59 billion | Fiscal year 2011: $2.80 billion | Fiscal year 2010: $2.90 billion | Fiscal year 2009: $2.64 billion | Fiscal year 2008: $1.98 billion.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026